Zobrazeno 1 - 10
of 108
pro vyhledávání: '"P. J. Wijkstra"'
Autor:
Judith Elshof, Judith M. Vonk, Anouschka van der Pouw, Cella van Dijk, Petra Vos, Huib A.M. Kerstjens, Peter J. Wijkstra, Marieke L. Duiverman
Publikováno v:
Respiratory Research, Vol 24, Iss 1, Pp 1-10 (2023)
Abstract Background Non-invasive ventilation (NIV) is an evidence-based treatment for acute respiratory failure in chronic obstructive pulmonary disease (COPD). However, suboptimal application of NIV in clinical practice, possibly due to poor guideli
Externí odkaz:
https://doaj.org/article/63aadd43b0d341edb5b444d63db57b67
Autor:
Tim Raveling, Judith M. Vonk, Nicholas S. Hill, Peter C. Gay, Ciro Casanova, Enrico Clini, Thomas Köhnlein, Eduardo Márquez-Martin, Tessa Schneeberger, Patrick B. Murphy, Fransien M. Struik, Huib A.M. Kerstjens, Marieke L. Duiverman, Peter J. Wijkstra
Publikováno v:
ERJ Open Research, Vol 10, Iss 1 (2024)
Background Not all hypercapnic COPD patients benefit from home noninvasive ventilation (NIV), and mechanisms through which NIV improves clinical outcomes remain uncertain. We aimed to identify “responders” to home NIV, denoted by a beneficial eff
Externí odkaz:
https://doaj.org/article/8d10fde96c9d43b1bdaaa3a90a583d97
Autor:
Ries J.M. van den Biggelaar, A. Hazenberg, N. A.M. Cobben, M. A. Gaytant, D. A.M.P.J. Gommers, P. J. Wijkstra
Publikováno v:
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background and objective In the current study, we undertook a more detailed exploration of the reasons why patients undergoing HMV were screened out of a recently published study in order to better understand how applicable home initiation o
Externí odkaz:
https://doaj.org/article/1dd20145360a4ef9954170c5c534dcc4
Autor:
Paola Pierucci, Claudia Crimi, Annalisa Carlucci, Giovanna E. Carpagnano, Jean-Paul Janssens, Manel Lujan, Alberto Noto, Peter J. Wijkstra, Wolfram Windisch, Raffaele Scala
Publikováno v:
ERJ Open Research, Vol 7, Iss 2 (2021)
Background and aim Little is known about the current use of long-term home noninvasive ventilation (LTHNIV) in restrictive thoracic diseases, including chest wall disorders and neuromuscular disorders (NMD). This study aimed to capture the pattern of
Externí odkaz:
https://doaj.org/article/171d29283bc140ec95f764b37e4a0c7b
Autor:
Marlies van Dijk, Christiaan T. Gan, T. David Koster, Peter J. Wijkstra, Dirk-Jan Slebos, Huib A.M. Kerstjens, Hester van der Vaart, Marieke L. Duiverman
Publikováno v:
ERJ Open Research, Vol 6, Iss 3 (2020)
Now that additional treatment options for severe chronic obstructive pulmonary disease (COPD) have emerged in recent years, patients with severe COPD should not be left in the rather hopeless situation of “there is nothing to improve” any more. I
Externí odkaz:
https://doaj.org/article/43e45b9830974e079e803f2a241d31f7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
02.02 - Noninvasive ventilatory support.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fb510a91fcbd2ec847e538b0659c8e7
https://doi.org/10.1183/13993003.congress-2022.2247
https://doi.org/10.1183/13993003.congress-2022.2247
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 10 (2016)
Recently, clear benefits have been shown from long-term noninvasive ventilation (NIV) in stable chronic obstructive pulmonary disease (COPD) patients with chronic hypercapnic respiratory failure. In our opinion, these benefits are confirmed and noctu
Externí odkaz:
https://doaj.org/article/23bed7e189dc483e80b438090529d3bc
Autor:
P J, Wijkstra, M L, Duiverman
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 165
Prescription of long term oxygen treatment ( LTOT),based on old studies, is only indicated if there is severe hypoxaemia at rest (PaO28,0 kPa) and should be used atleast 15 hours per day.However as newer treatments like nocturnal non-invasive ventila
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::19f43ddebbf0c460aa9a3761828eac8d
https://pubmed.ncbi.nlm.nih.gov/34346595
https://pubmed.ncbi.nlm.nih.gov/34346595
Autor:
J C, van den Bergen, H B, Ginjaar, A J, van Essen, R, Pangalila, I J M, de Groot, P J, Wijkstra, M P, Zijnen, N A M, Cobben, M J, Kampelmacher, B H A, Wokke, I F M, de Coo, J M, Fock, A M C, Horemans, M, van Tol, E, Vroom, M E B, Rijlaarsdam, C S M, Straathof, E H, Niks, J J G M, Verschuuren
Publikováno v:
Journal of neuromuscular diseases. 1(1)
Duchenne muscular dystrophy (DMD) is a progressive muscle disease. No curative therapy is currently available, but in recent decades standards of care have improved. These improvements include the use of corticosteroids and mechanical ventilation.To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9ac9903fe763610bd21edc9dbec33ead
https://pubmed.ncbi.nlm.nih.gov/27858664
https://pubmed.ncbi.nlm.nih.gov/27858664